Excessive activation of N-methyl-D-aspartate (NMDA) receptors leads to cell
death in human embryonic kidney-293 (HEK) cells which have been transfecte
d with recombinant NMDA receptors. To evaluate the role of protein kinase C
(PKC) activation in NMDA-mediated toxicity, we have analyzed the survival
of transfected HEK cells using trypan blue exclusion. We found that NMDA-me
diated death of HEK cells transfected with NR1/NR2A subunits was increased
by exposure to phorbol esters and reduced by inhibitors of PKC activation,
or PKC down-regulation. The region of NR2A that provides the PKC-induced en
hancement of cell death was localized to a discrete segment of the C-termin
us. Use of isoform-specific PKC inhibitors showed that Ca2+- and lipid-depe
ndent PKC isoforms (cPKCs), specifically PKC beta1, was responsible for the
increase in cell death when phorbol esters were applied prior to NMDA in t
hese cells. PKC activity measured by an in vitro kinase assay was also incr
eased in NR1A/NR2A-transfected HEK cells following NMDA stimulation. These
results suggest that PKC acts on the C-terminus of NR2A to accentuate cell
death in NR1/NR2A-transfected cells and demonstrate that this effect is med
iated by cPKC isoforms. These data indicate that elevation of cellular PKC
activity can increase neurotoxicity mediated by NMDA receptor activation.